We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRTX
1776
TPG RE Finance Trust
TRTX
$610M
$247K ﹤0.01%
28,755
+6,027
+27% +$43.8K
DHT icon
1777
DHT Holdings
DHT
$3.01B
$247K ﹤0.01%
48,147
– –
KIDS icon
1778
OrthoPediatrics
KIDS
$649M
$246K ﹤0.01%
5,617
+1,009
+22% +$45.4K
COLL icon
1779
Collegium Pharmaceutical
COLL
$834M
$246K ﹤0.01%
14,032
– –
NGNE icon
1780
Neurogene
NGNE
$740M
$245K ﹤0.01%
+739
New +$193K
REPL icon
1781
Replimune Group
REPL
$1.43B
$245K ﹤0.01%
+9,865
New +$174K
IHRT icon
1782
iHeartMedia
IHRT
$450M
$244K ﹤0.01%
+29,273
New +$228K
VBIV
1783
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$244K ﹤0.01%
+2,619
New +$144K
AER icon
1784
AerCap
AER
$23.6B
$243K ﹤0.01%
7,900
– –
IGMS
1785
DELISTED
IGM Biosciences
IGMS
$243K ﹤0.01%
3,333
+896
+37% +$54.4K
RPT
1786
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$243K ﹤0.01%
34,953
– –
KRA
1787
DELISTED
Kraton Corporation
KRA
$242K ﹤0.01%
14,021
– –
ELF icon
1788
e.l.f. Beauty
ELF
$5.47B
$242K ﹤0.01%
12,689
– –
QTTB icon
1789
Q32 Bio
QTTB
$458M
$242K ﹤0.01%
884
+218
+33% +$58.1K
EBIX
1790
DELISTED
Ebix Inc
EBIX
$242K ﹤0.01%
10,806
– –
CIO
1791
DELISTED
City Office REIT
CIO
$241K ﹤0.01%
23,989
– –
EVRI
1792
DELISTED
Everi Holdings
EVRI
$241K ﹤0.01%
46,713
+14,895
+47% +$75.7K
SPWR
1793
DELISTED
SunPower Corporation Common Stock
SPWR
$241K ﹤0.01%
48,029
– –
EGRX
1794
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$239K ﹤0.01%
4,988
– –
AEGN
1795
DELISTED
Aegion Corp
AEGN
$239K ﹤0.01%
15,075
– –
AHRT
1796
AH Realty Trust
AHRT
$501M
$239K ﹤0.01%
23,985
– –
CODX
1797
Co-Diagnostics
CODX
$5.45M
$238K ﹤0.01%
+410
New +$187K
LXFR icon
1798
Luxfer Holdings
LXFR
$457M
$238K ﹤0.01%
16,801
+6,203
+59% +$85.5K
UVE icon
1799
Universal Insurance Holdings
UVE
$1.18B
$237K ﹤0.01%
13,371
– –
KELYA icon
1800
Kelly Services Class A
KELYA
$536M
$236K ﹤0.01%
14,944
– –
70 71
72
73 74

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.